Insider Trading Activity TrovaGene Inc (NASDAQ:TROV) – Director Bought 10,000 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For TrovaGene Inc (NASDAQ:TROV)

Stanley Tennant , Director of TrovaGene Inc (NASDAQ:TROV) reportedly Bought 10,000 shares of the company’s stock at an average price of 0.8 for a total transaction amount of $8,000.00 SEC Form

Insider Trading History For TrovaGene Inc (NASDAQ:TROV)

On 8/16/2012 Gabriel Cerrone, Director, bought 15,000 with an average share price of $2.24 per share and the total transaction amounting to $33,600.00.

On 8/20/2012 Gabriel Cerrone, Director, bought 7,800 with an average share price of $2.35 per share and the total transaction amounting to $18,330.00.

On 11/30/2012 Stanley Tennant, Director, bought 25,000 with an average share price of $4.82 per share and the total transaction amounting to $120,500.00.

On 9/3/2013 Thomas Phd Adams, Director, sold 19,200 with an average share price of $8.19 per share and the total transaction amounting to $157,248.00.

On 6/9/2014 Steve Zaniboni, CFO, bought 6,329 with an average share price of $3.95 per share and the total transaction amounting to $24,999.55.

On 2/6/2015 Bridger Management, Llc, Major Shareholder, bought 444,444 with an average share price of $4.50 per share and the total transaction amounting to $1,999,998.00.

On 2/27/2015 Bridger Management, Llc, Major Shareholder, bought 263,286 with an average share price of $5.36 per share and the total transaction amounting to $1,411,212.96.

Analyst Ratings History For TrovaGene Inc (NASDAQ:TROV)

On 3/16/2017 Piper Jaffray Companies Downgraded rating Neutral ➝ Underweight
On 8/8/2017 Cantor Fitzgerald Reiterated Rating Overweight
On 5/9/2018 Maxim Group Reiterated Rating Hold
On 6/4/2018 HC Wainwright Set Price Target of rating Buy with a price target of $7.00

Recent Trading Activity for TrovaGene Inc (NASDAQ:TROV)
Shares of TrovaGene Inc closed the previous trading session at 0.89 down -0.03 3.26% with 971158 shares trading hands.